MOSCOW (Reuters) - The Russian Direct Investment Fund (RDIF) sovereign wealth fund said on Monday (April 19) that it had agreed with Chinese manufacturer Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V Covid-19 vaccine in China.

RDIF said the two sides were committed to a long-term partnership in vaccine production.

This story is developing.